Abstract
The role of oncogenes in pituitary tumorigenesis remains elusive since few genetic changes have been identified so far in pituitary tumors. Pituitary tumor-transforming gene (pttg) has been recently cloned from rat GH4 pituitary tumor cells. We have previously isolated and characterized hpttg from human thymus. In the present study, we analyse the expression of hpttg mRNA in a series of human pituitary adenomas. We show that hpttg is highly expressed in the majority of pituitary adenomas while only very low levels of mRNA can be detected in normal pituitary gland by Northern blot analysis. hPTTG protein was immunolocalized mainly in the cytoplasm of adenoma cells. Other common extra-cranial malignant tumors were also analysed by immunohistochemistry. Interestingly, strong hPTTG immunoreactivity was detected in most adenocarcinomas of mammary and pulmonary origins.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexander JM, Biller BMK, Bikkal H, Zervas NT, Arnold A and Klibanski A. . 1990 J. Clin. Invest. 86: 336–340.
Alvaro V, Lévy L, Dubray C, Roche A, Peillon F, Quérat B and Joubert D. . 1993 J. Clin. Endocrinol. Metab. 77: 1125–1129.
Asa SL, Kovacs K, Stefaneanu L, Horvath E, Billestrup N, Gonzalez-Mancho C and Vale W. . 1992 Endocrinology 131: 2083–2089.
Bertherat J, Chanson P and Montminy MR. . 1995 Mol. Endocrinol. 9: 777–783.
Burton FH, Hasel KW, Bloom FE and Sutcliffe JG. . 1991 Nature 350: 74–77.
Cryns VL, Alexander JM, Klibanski A and Arnold A. . 1993 J. Clin. Endocrinol. Metab. 77: 644–646.
Domínguez A, Ramos-Morales F, Romero F, Ríos RM, Dreyfus F, Tortolero M and Pintor-Toro JA. . 1998 Oncogene 17: 2187–2193.
Herman V, Drazin NZ, Gonsky R and Melmed S. . 1993 J. Clin. Endocrinol. Metab. 77: 50–55.
Herman V, Fagin J, Gonsky R, Kovacs K and Melmed S. . 1990 J. Clin. Endocrinol. Metab. 71: 1427–1433.
Karga HJ, Alexander JM, Hedley-White ET, Klibanski A and Jameson JL. . 1992 J. Clin. Endocrinol. Metab. 74: 914–919.
Landis C, Master SB, Spada A, Pace AM, Bourne HR and Vallar L. . 1989 Nature 340: 692–696.
Liu X, Robinson GW, Wagner K-U, Garrett L, Wynshaw-Boris A and Henninghausen L. . 1997 Genes Dev. 11: 179–186.
Lyons J, Landis CA, Harsh G, Vallar L, Grünewald K, Feichtinger H, Duh Q-Y, Clark OH, Kawasaki E, Bourne HR and McCormick F. . 1990 Science 249: 255–259.
McAndrew J, Paterson AJ, Asa SL, McCarthy KJ and Kudlow JE. . 1995 Endocrinology 136: 4479–4488.
Pei L and Melmed S. . 1997 Mol. Endocrinol. 11: 433–441.
Pei L, Melmed S, Scheithauer B, Kovacs K and Prager D. . 1994 J. Clin. Endocrinol. Metab. 78: 842–846.
Spada A, Vallar L and Faglia G. . 1994 Eur. J. Endocrinol. 130: 43–52.
Strausberg RL, Dahl CA and Klausner RD. . 1997 Nat. Genet. 15: 415–416.
Sumi T, Stefaneanu L, Kovacs K, Asa SL and Rindi G. . 1993 Endocrine Pathol. 4: 95–99.
Thapar K, Kovacs K and Muller P. . 1995 Clin. Endocrinol. Metab. 9: 243–270.
Zhang X, Horwitz GA, Prezant TR, Valentini A, Nakashima M, Bronstein MD and Melmed S. . 1999 Mol. Endocrinol. 13: 156–166.
Zhuang Z, Ezzat SZ, Vortmeyer AO, Weil R, Oldfield EH, Park W-S, Pack S, Huang S, Agarwal SK, Guru SC, Manickam P, Debelenko LV, Kester MB, Olufemi SE, Heppner C, Crabtree JS, Burns AL, Spiegel AM, Marx SJ, Chandrasekharappa SC, Collins FS, Emmert-Buck MR, Liotta LA, Asa SL and Lubensky IA. . 1997 Cancer Res. 57: 5446–5451.
Acknowledgements
We are grateful to Malcolm J Low for critical reading of the manuscript, and to the members of the Pituitary Tumors Collaborative Group (HUVR) for continuous support. This work was supported by grants from Ministerio de Educación y Ciencia of Spain (SAF96-0275), Fundación ANDEX (to C Sáez) and DGUI of the Junta de Andalucía.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sáez, C., Japón, M., Ramos-Morales, F. et al. hpttg is over-expressed in pituitary adenomas and other primary epithelial neoplasias. Oncogene 18, 5473–5476 (1999). https://doi.org/10.1038/sj.onc.1202914
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202914
Keywords
This article is cited by
-
Securin overexpression correlates with the activated Rb/E2F1 pathway and histone H3 epigenetic modifications in raw areca nut-induced carcinogenesis in mice
Cancer Cell International (2022)
-
Expression of cell cycle regulators and biomarkers of proliferation and regrowth in human pituitary adenomas
Pituitary (2017)
-
Molecular Mechanisms Underlying Pituitary Pathogenesis
Biochemical Genetics (2016)
-
PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma
Journal of Hematology & Oncology (2015)
-
Changes in PTTG1 by human TERT gene expression modulate the self-renewal of placenta-derived mesenchymal stem cells
Cell and Tissue Research (2014)